Systematic review of economic evaluations for paediatric pulmonary diseases

Abstract Background Paediatric pulmonary diseases are the leading causes of mortality amongst children under five globally. Economic evaluations (EEs) seek to guide decision-makers on which health care interventions to adopt to reduce the paediatric pulmonary disease burden. This study aims to syste...

Full description

Bibliographic Details
Main Authors: Mutsawashe Chitando, Susan Cleary, Lucy Cunnama
Format: Article
Language:English
Published: BMC 2023-04-01
Series:Cost Effectiveness and Resource Allocation
Subjects:
Online Access:https://doi.org/10.1186/s12962-023-00423-1
_version_ 1797836416430899200
author Mutsawashe Chitando
Susan Cleary
Lucy Cunnama
author_facet Mutsawashe Chitando
Susan Cleary
Lucy Cunnama
author_sort Mutsawashe Chitando
collection DOAJ
description Abstract Background Paediatric pulmonary diseases are the leading causes of mortality amongst children under five globally. Economic evaluations (EEs) seek to guide decision-makers on which health care interventions to adopt to reduce the paediatric pulmonary disease burden. This study aims to systematically review economic evaluations on different aspects of the inpatient management of paediatric pulmonary diseases globally. Methods We systematically reviewed EEs published between 2010 and 2020, with a subsequent search conducted for 2020–2022. We searched PubMed, Web of Science, MEDLINE, Paediatric Economic Database Evaluation (PEDE) and the Cochrane library. We extracted data items guided by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. We collected qualitative and quantitative data which we analysed in Microsoft Excel and R software. Results Twenty-two articles met the inclusion criteria. Six of the articles were cost-effectiveness analyses, six cost-utility analyses, two cost-minimisation analyses and eight cost analyses. Twelve articles were from high-income countries (HICs) and ten were from low- and middle-income countries (LMICs). Eight articles focused on asthma, eleven on pneumonia, two on asthma and pneumonia, and one on tuberculosis. Conclusion Conducting more EEs for paediatric pulmonary diseases in LMICs could allow for more evidence-based decision-making to improve paediatric health outcomes.
first_indexed 2024-04-09T15:09:18Z
format Article
id doaj.art-6ac8600d8669488e80bf36eecb4acdc4
institution Directory Open Access Journal
issn 1478-7547
language English
last_indexed 2024-04-09T15:09:18Z
publishDate 2023-04-01
publisher BMC
record_format Article
series Cost Effectiveness and Resource Allocation
spelling doaj.art-6ac8600d8669488e80bf36eecb4acdc42023-04-30T11:17:43ZengBMCCost Effectiveness and Resource Allocation1478-75472023-04-0121111010.1186/s12962-023-00423-1Systematic review of economic evaluations for paediatric pulmonary diseasesMutsawashe Chitando0Susan Cleary1Lucy Cunnama2Health Economics Unit and Division, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape TownHealth Economics Unit and Division, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape TownHealth Economics Unit and Division, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape TownAbstract Background Paediatric pulmonary diseases are the leading causes of mortality amongst children under five globally. Economic evaluations (EEs) seek to guide decision-makers on which health care interventions to adopt to reduce the paediatric pulmonary disease burden. This study aims to systematically review economic evaluations on different aspects of the inpatient management of paediatric pulmonary diseases globally. Methods We systematically reviewed EEs published between 2010 and 2020, with a subsequent search conducted for 2020–2022. We searched PubMed, Web of Science, MEDLINE, Paediatric Economic Database Evaluation (PEDE) and the Cochrane library. We extracted data items guided by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist. We collected qualitative and quantitative data which we analysed in Microsoft Excel and R software. Results Twenty-two articles met the inclusion criteria. Six of the articles were cost-effectiveness analyses, six cost-utility analyses, two cost-minimisation analyses and eight cost analyses. Twelve articles were from high-income countries (HICs) and ten were from low- and middle-income countries (LMICs). Eight articles focused on asthma, eleven on pneumonia, two on asthma and pneumonia, and one on tuberculosis. Conclusion Conducting more EEs for paediatric pulmonary diseases in LMICs could allow for more evidence-based decision-making to improve paediatric health outcomes.https://doi.org/10.1186/s12962-023-00423-1PaediatricPulmonary diseaseEconomic evaluationSystematic review
spellingShingle Mutsawashe Chitando
Susan Cleary
Lucy Cunnama
Systematic review of economic evaluations for paediatric pulmonary diseases
Cost Effectiveness and Resource Allocation
Paediatric
Pulmonary disease
Economic evaluation
Systematic review
title Systematic review of economic evaluations for paediatric pulmonary diseases
title_full Systematic review of economic evaluations for paediatric pulmonary diseases
title_fullStr Systematic review of economic evaluations for paediatric pulmonary diseases
title_full_unstemmed Systematic review of economic evaluations for paediatric pulmonary diseases
title_short Systematic review of economic evaluations for paediatric pulmonary diseases
title_sort systematic review of economic evaluations for paediatric pulmonary diseases
topic Paediatric
Pulmonary disease
Economic evaluation
Systematic review
url https://doi.org/10.1186/s12962-023-00423-1
work_keys_str_mv AT mutsawashechitando systematicreviewofeconomicevaluationsforpaediatricpulmonarydiseases
AT susancleary systematicreviewofeconomicevaluationsforpaediatricpulmonarydiseases
AT lucycunnama systematicreviewofeconomicevaluationsforpaediatricpulmonarydiseases